Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG
LAMIFERON
Phase 2 small_molecule active
Quick answer
Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG for Mild Cognitive impairment due to Alzheimer Disease is a Phase 2 program (small_molecule) at Meda AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Meda AB
- Indication
- Mild Cognitive impairment due to Alzheimer Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active